FDA Drug Recalls

Recalls / Class I

Class ID-0253-2022

Class I— FDA's most serious classification, issued when there is a reasonable probability that use of or exposure to the drug will cause serious adverse health consequences or death.

Product

Tinactin (Tolnaftate 1%) POWDER SPRAY NET WT 133g (4.6 oz) can, labeled as (a) Product of Ireland 86940418; (b)Product of Finland 20006106; Dist by: Bayer Healthcare LLC, Whippany, NJ 07981, Product of Finland, UPC 3 11017 41009 7, NDC 11523-0777-2.

Affected lot / code info
Lot # (a)CV015YS, EXP 9/30/2021 (b) TN008CT, TN007TJ, EXP 3/31/2023

Why it was recalled

Chemical Contamination: presence of benzene

Recalling firm

Firm
Bayer Healthcare Pharmaceuticals Inc.
Notification channel
Press Release
Type
Voluntary: Firm initiated
Address
100 Bayer Blvd, N/A, Whippany, New Jersey 07981-1544

Distribution

Quantity
2,841,012 cans
Distribution pattern
Distributed Nationwide in the US, Puerto Rico, Canada and Mexico through a variety of retail channels.

Timeline

Recall initiated
2021-10-01
FDA classified
2021-11-18
Posted by FDA
2021-11-24
Terminated
2023-06-26
Status
Terminated

Source: openFDA Drug Enforcement endpoint. Recall record D-0253-2022. The FDA issues recall classifications as health-hazard assessments, not legal findings; for legal claims consult a licensed attorney.